Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6808172 | 0.89 | ITGB1 (0.47) | ITGB1ITGA4 | |
| SCHEMBL6807361 | 0.86 | MAPT (0.47) | ITGB1ITGA4 | |
| SCHEMBL6802062 | 0.83 | ITGB1 (0.51) | ITGB1ITGA4 | |
| SCHEMBL6808212 | 0.81 | ITGB1 (0.54) | ITGB1ITGA4 | |
| SCHEMBL4595682 | 0.80 | ALDH1A1 (0.56) | — | |
| SCHEMBL4596801 | 0.80 | ALDH1A1 (0.56) | — | |
| SCHEMBL4597348 | 0.79 | ALDH1A1 (0.57) | — | |
| SCHEMBL4596955 | 0.79 | ALDH1A1 (0.57) | — | |
| SCHEMBL6803246 | 0.72 | ITGB1 (0.46) | ITGB1ITGA4 | |
| SCHEMBL2983988 | 0.72 | ITGB1 (0.61) | ITGB1ITGA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040039040-A1 | Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient | TORAY INDUSTRIES, INC. (JP) | 2004-02-26 | — | — | US | disclosed |
| EP-1323709-A1 | UREA DERIVATIVE AND ADHESIVE-MOLECULE INHIBITOR CONTAINING THE SAME AS ACTIVE INGREDIENT | TORAY INDUSTRIES, INC. (JP) | 2003-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040039040-A1 | Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient | ICAM1, VCAM1, EPCAM | ITGB1 55/4885ITGA4 221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.